{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:34:31Z","timestamp":1771655671600,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI112722"],"award-info":[{"award-number":["R21AI112722"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573213"],"award-info":[{"award-number":["81573213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China Mega-Project for Infectious Diseases","award":["2013ZX10002005-002-005"],"award-info":[{"award-number":["2013ZX10002005-002-005"]}]},{"name":"National Science Foundation of Jiangsu Province","award":["BK20161059"],"award-info":[{"award-number":["BK20161059"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s12026-017-8913-3","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T02:08:13Z","timestamp":1489370893000},"page":"739-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Blockade of Notch signaling promotes acetaminophen-induced liver injury"],"prefix":"10.1007","volume":"65","author":[{"given":"Longfeng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youde","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Long","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1885-1538","authenticated-orcid":false,"given":"Bibo","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"8913_CR1","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/hep.20948","volume":"42","author":"AM Larson","year":"2005","unstructured":"Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364\u201372.","journal-title":"Hepatology"},{"key":"8913_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/MCG.0b013e31818a3854","volume":"43","author":"LJ Chun","year":"2009","unstructured":"Chun LJ, Tong MJ, Busuttil RW, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol. 2009;43:342\u20139.","journal-title":"J Clin Gastroenterol"},{"key":"8913_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jss.2012.11.051","volume":"180","author":"JE Fisher","year":"2013","unstructured":"Fisher JE, McKenzie TJ, Lillegard JB, Yu Y, Juskewitch JE, Nedredal GI, et al. Role of Kupffer cells and toll-like receptor 4 in acetaminophen-induced acute liver failure. J Surg Res. 2013;180:147\u201355.","journal-title":"J Surg Res"},{"key":"8913_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/hep.25657","volume":"56","author":"CG Antoniades","year":"2012","unstructured":"Antoniades CG, Quaglia A, Taams LS, Mitry RR, Hussain M, Abeles R, et al. Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology. 2012;56:735\u201346.","journal-title":"Hepatology"},{"key":"8913_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783\u2013801.","journal-title":"Cell"},{"key":"8913_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2010.01.004","volume":"32","author":"F Radtke","year":"2010","unstructured":"Radtke F, Fasnacht N, Macdonald HR. Notch signaling in the immune system. Immunity. 2010;32:14\u201327.","journal-title":"Immunity"},{"key":"8913_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/dbio.2000.9960","volume":"228","author":"JS Mumm","year":"2000","unstructured":"Mumm JS, Kopan R. Notch signaling: from the outside in. Dev Biol. 2000;228:151\u201365.","journal-title":"Dev Biol"},{"key":"8913_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.semcancer.2004.04.011","volume":"14","author":"EM Hansson","year":"2004","unstructured":"Hansson EM, Lendahl U, Chapman G. Notch signaling in development and disease. Semin Cancer Biol. 2004;14:320\u20138.","journal-title":"Semin Cancer Biol"},{"key":"8913_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","volume":"137","author":"R Kopan","year":"2009","unstructured":"Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216\u201333.","journal-title":"Cell"},{"key":"8913_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm2009","volume":"7","author":"SJ Bray","year":"2006","unstructured":"Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006;7:678\u201389.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8913_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nri3445","volume":"13","author":"F Radtke","year":"2013","unstructured":"Radtke F, MacDonald HR, Tacchini-Cottier F. Regulation of innate and adaptive immunity by Notch. Nat Rev Immunol. 2013;13:427\u201337.","journal-title":"Nat Rev Immunol."},{"key":"8913_CR12","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/hep.20156","volume":"39","author":"C Kohler","year":"2004","unstructured":"Kohler C, Bell AW, Bowen WC, Monga SP, Fleig W, Michalopoulos GK. Expression of Notch-1 and its ligand jagged-1 in rat liver during liver regeneration. Hepatology. 2004;39:1056\u201365.","journal-title":"Hepatology"},{"key":"8913_CR13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/hep.24469","volume":"54","author":"HC Yu","year":"2011","unstructured":"Yu HC, Qin HY, He F, Wang L, Fu W, Liu D, et al. Canonical notch pathway protects hepatocytes from ischemia\/reperfusion injury in mice by repressing reactive oxygen species production through JAK2\/STAT3 signaling. Hepatology. 2011;54:979\u201388.","journal-title":"Hepatology"},{"key":"8913_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","volume":"27","author":"F Martinon","year":"2009","unstructured":"Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27:229\u201365.","journal-title":"Annu Rev Immunol"},{"key":"8913_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-cellbio-101011-155745","volume":"28","author":"M Lamkanfi","year":"2012","unstructured":"Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol. 2012;28:137\u201361.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"8913_CR16","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","volume":"140","author":"DL Kastner","year":"2010","unstructured":"Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010;140:784\u201390.","journal-title":"Cell"},{"key":"8913_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008;9:857\u201365.","journal-title":"Nat Immunol"},{"key":"8913_CR18","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464:1357\u201361.","journal-title":"Nature"},{"key":"8913_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature10759","volume":"481","author":"T Strowig","year":"2012","unstructured":"Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481:278\u201386.","journal-title":"Nature"},{"key":"8913_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015;160:62\u201373.","journal-title":"Cell"},{"key":"8913_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/db12-0420","volume":"62","author":"HM Lee","year":"2013","unstructured":"Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ, Jo EK. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes. 2013;62:194\u2013204.","journal-title":"Diabetes"},{"key":"8913_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17:179\u201388.","journal-title":"Nat Med"},{"key":"8913_CR23","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493:674\u20138.","journal-title":"Nature"},{"key":"8913_CR24","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/hep.28739","volume":"64","author":"S Yue","year":"2016","unstructured":"Yue S, Zhu J, Zhang M, Li C, Zhou X, Zhou M, et al. The myeloid heat shock transcription factor 1\/beta-catenin axis regulates NLR family, pyrin domain-containing 3 inflammasome activation in mouse liver ischemia\/reperfusion injury. Hepatology. 2016;64:1683\u201398.","journal-title":"Hepatology"},{"key":"8913_CR25","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/mt.2009.285","volume":"18","author":"B Ke","year":"2010","unstructured":"Ke B, Shen XD, Gao F, Ji H, Qiao B, Zhai Y, et al. Adoptive transfer of ex vivo HO-1 modified bone marrow-derived macrophages prevents liver ischemia and reperfusion injury. Mol Ther. 2010;18:1019\u201325.","journal-title":"Mol Ther"},{"key":"8913_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jhep.2011.05.023","volume":"56","author":"B Ke","year":"2012","unstructured":"Ke B, Shen XD, Ji H, Kamo N, Gao F, Freitas MC, et al. HO-1-STAT3 axis in mouse liver ischemia\/reperfusion injury: regulation of TLR4 innate responses through PI3K\/PTEN signaling. J Hepatol. 2012;56:359\u201366.","journal-title":"J Hepatol"},{"key":"8913_CR27","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrg3272","volume":"13","author":"KG Guruharsha","year":"2012","unstructured":"Guruharsha KG, Kankel MW, Artavanis-Tsakonas S. The Notch signalling system: recent insights into the complexity of a conserved pathway. Nat Rev Genet. 2012;13:654\u201366.","journal-title":"Nat Rev Genet"},{"key":"8913_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499\u2013511.","journal-title":"Nat Rev Immunol"},{"key":"8913_CR29","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/hep.1840210424","volume":"21","author":"DL Laskin","year":"1995","unstructured":"Laskin DL, Gardner CR, Price VF, Jollow DJ. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology. 1995;21:1045\u201350.","journal-title":"Hepatology"},{"key":"8913_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/hep.510300104","volume":"30","author":"SL Michael","year":"1999","unstructured":"Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology. 1999;30:186\u201395.","journal-title":"Hepatology"},{"key":"8913_CR31","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/hep.21549","volume":"45","author":"H Jaeschke","year":"2007","unstructured":"Jaeschke H, Liu J. Neutrophil depletion protects against murine acetaminophen hepatotoxicity: another perspective. Hepatology. 2007;45:1588\u20139. Author reply 9","journal-title":"Hepatology"},{"key":"8913_CR32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1182\/blood-2007-05-087353","volume":"111","author":"DT Teachey","year":"2008","unstructured":"Teachey DT, Seif AE, Brown VI, Bruno M, Bunte RM, Chang YJ, et al. Targeting Notch signaling in autoimmune and lymphoproliferative disease. Blood. 2008;111:705\u201314.","journal-title":"Blood"},{"key":"8913_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuroscience.2012.02.051","volume":"210","author":"S Nasoohi","year":"2012","unstructured":"Nasoohi S, Hemmati AA, Moradi F, Ahmadiani A. The gamma-secretase blocker DAPT impairs recovery from lipopolysaccharide-induced inflammation in rat brain. Neuroscience. 2012;210:99\u2013109.","journal-title":"Neuroscience"},{"key":"8913_CR34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2119\/molmed.2014.00103","volume":"20","author":"J Huang","year":"2014","unstructured":"Huang J, Shen XD, Yue S, Zhu J, Gao F, Zhai Y, et al. Adoptive transfer of heme oxygenase-1 (HO-1)-modified macrophages rescues the nuclear factor erythroid 2-related factor (Nrf2) antiinflammatory phenotype in liver ischemia\/reperfusion injury. Mol Med. 2014;20:448\u201355.","journal-title":"Mol Med"},{"key":"8913_CR35","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248\u201351.","journal-title":"Science"},{"key":"8913_CR36","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.4049\/jimmunol.165.6.2950","volume":"165","author":"E Abraham","year":"2000","unstructured":"Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000;165:2950\u20134.","journal-title":"J Immunol"},{"key":"8913_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00109-012-0946-4","volume":"19","author":"R Chen","year":"2013","unstructured":"Chen R, Hou W, Zhang Q, Kang R, Fan XG, Tang D. Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. Mol Med. 2013;19:357\u201366.","journal-title":"Mol Med"},{"key":"8913_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1478-3231.2011.02501.x","volume":"32","author":"H Jaeschke","year":"2012","unstructured":"Jaeschke H, Williams CD, Ramachandran A, Bajt ML. Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int. 2012;32:8\u201320.","journal-title":"Liver Int"},{"key":"8913_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/SHK.0b013e318186262d","volume":"31","author":"MA van Zoelen","year":"2009","unstructured":"van Zoelen MA, Yang H, Florquin S, Meijers JC, Akira S, Arnold B, et al. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock. 2009;31:280\u20134.","journal-title":"Shock"},{"key":"8913_CR40","doi-asserted-by":"publisher","first-page":"11942","DOI":"10.1073\/pnas.1003893107","volume":"107","author":"H Yang","year":"2010","unstructured":"Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A. 2010;107:11942\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8913_CR41","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20042614","volume":"201","author":"A Tsung","year":"2005","unstructured":"Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. 2005;201:1135\u201343.","journal-title":"J Exp Med"},{"key":"8913_CR42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/hep.25982","volume":"57","author":"X Wang","year":"2013","unstructured":"Wang X, Sun R, Wei H, Tian Z. High-mobility group box 1 (HMGB1)-toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: interaction of gammadelta T cells with macrophages. Hepatology. 2013;57:373\u201384.","journal-title":"Hepatology"},{"key":"8913_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.molimm.2015.03.009","volume":"66","author":"A Zhang","year":"2015","unstructured":"Zhang A, Wang P, Ma X, Yin X, Li J, Wang H, et al. Mechanisms that lead to the regulation of NLRP3 inflammasome expression and activation in human dental pulp fibroblasts. Mol Immunol. 2015;66:253\u201362.","journal-title":"Mol Immunol"},{"key":"8913_CR44","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.0901363","volume":"183","author":"FG Bauernfeind","year":"2009","unstructured":"Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183:787\u201391.","journal-title":"J Immunol"},{"key":"8913_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.immuni.2008.08.016","volume":"29","author":"X Hu","year":"2008","unstructured":"Hu X, Chung AY, Wu I, Foldi J, Chen J, Ji JD, et al. Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. Immunity. 2008;29:691\u2013703.","journal-title":"Immunity"},{"key":"8913_CR46","doi-asserted-by":"publisher","first-page":"16537","DOI":"10.1073\/pnas.0404429101","volume":"101","author":"C Aguilera","year":"2004","unstructured":"Aguilera C, Hoya-Arias R, Haegeman G, Espinosa L, Bigas A. Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression. Proc Natl Acad Sci U S A. 2004;101:16537\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8913_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1158\/1535-7163.MCT-06-0561","volume":"6","author":"SR Choudhari","year":"2007","unstructured":"Choudhari SR, Khan MA, Harris G, Picker D, Jacob GS, Block T, et al. Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod. Mol Cancer Ther. 2007;6:112\u201321.","journal-title":"Mol Cancer Ther"},{"key":"8913_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.canlet.2009.09.014","volume":"290","author":"WL Shih","year":"2010","unstructured":"Shih WL, Liao MH, Lin PY, Chang CI, Cheng HL, Yu FL, et al. PI 3-kinase\/Akt and STAT3 are required for the prevention of TGF-beta-induced Hep3B cell apoptosis by autocrine motility factor\/phosphoglucose isomerase. Cancer Lett. 2010;290:223\u201337.","journal-title":"Cancer Lett"},{"key":"8913_CR49","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/ncb1138","volume":"6","author":"S Kamakura","year":"2004","unstructured":"Kamakura S, Oishi K, Yoshimatsu T, Nakafuku M, Masuyama N, Gotoh Y. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol. 2004;6:547\u201354.","journal-title":"Nat Cell Biol"},{"key":"8913_CR50","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1172\/JCI9940","volume":"107","author":"PK Epling-Burnette","year":"2001","unstructured":"Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest. 2001;107:351\u201362.","journal-title":"J Clin Invest"},{"key":"8913_CR51","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1042\/BJ20081056","volume":"415","author":"V Duronio","year":"2008","unstructured":"Duronio V. The life of a cell: apoptosis regulation by the PI3K\/PKB pathway. Biochem J. 2008;415:333\u201344.","journal-title":"Biochem J"},{"key":"8913_CR52","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.imbio.2014.03.020","volume":"219","author":"N Sangphech","year":"2014","unstructured":"Sangphech N, Osborne BA, Palaga T. Notch signaling regulates the phosphorylation of Akt and survival of lipopolysaccharide-activated macrophages via regulator of G protein signaling 19 (RGS19). Immunobiology. 2014;219:653\u201360.","journal-title":"Immunobiology"},{"key":"8913_CR53","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1083\/jcb.200509084","volume":"173","author":"M Moriyama","year":"2006","unstructured":"Moriyama M, Osawa M, Mak SS, Ohtsuka T, Yamamoto N, Han H, et al. Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J Cell Biol. 2006;173:333\u20139.","journal-title":"J Cell Biol"},{"key":"8913_CR54","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/hep.20437","volume":"40","author":"K Kon","year":"2004","unstructured":"Kon K, Kim JS, Jaeschke H, Lemasters JJ. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology. 2004;40:1170\u20139.","journal-title":"Hepatology"},{"key":"8913_CR55","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1002\/hep.21062","volume":"43","author":"H Malhi","year":"2006","unstructured":"Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology. 2006;43:S31\u201344.","journal-title":"Hepatology"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-017-8913-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-017-8913-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-017-8913-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:30:03Z","timestamp":1589733003000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-017-8913-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["8913"],"URL":"https:\/\/doi.org\/10.1007\/s12026-017-8913-3","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]},"assertion":[{"value":"13 March 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}